$HCWB up 37% 🚀 🔹 HCW Biologics catching major momentum after recent Q1 business highlights 📈 🔹 Company advancing its immunotherapy pipeline focused on cance

$HCWB up 37% 🚀 🔹 HCW Biologics catching major momentum after recent Q1 business highlights 📈 🔹 Company advancing its immunotherapy pipeline focused on cancer, autoimmune disease, and age-related inflammation 🧬 🔹 Recent buzz tied to HCW11-040 showing potential in IND-enabling studies for bronch…